INVESTMENT AGREEMENT
INVESTMENT
AGREEMENT (this "AGREEMENT"), dated as of August
23,
2007 by
and between SportsQuest, Inc., a Delaware corporation (the "Company"), and
Dutchess Private Equities Fund, Ltd., a Cayman Islands exempted company (the
"Investor").
As
used
in this Agreement, the following terms shall have the following meanings
specified or indicated below, and such meanings shall be equally applicable
to
the singular and plural forms of such defined terms.
“1933
Act” shall have the meaning set forth in the preamble of this
agreement.
“1934
Act” shall mean the Securities Exchange Act of 1934, as it may be
amended.
“Affiliate”
shall have the meaning specified in Section 5(H), below.
“Agreement”
shall mean this Investment Agreement.
“Best
Bid” shall mean the highest posted bid price of the Common Stock during a given
period of time.
“By-laws”
shall have the meaning specified in Section 4(C).
“Certificate
of Incorporation” shall have the meaning specified in Section 4(C).
“Closing”
shall have the meaning specified in Section 2(G).
“Closing
Date” shall mean no more than seven (7) Trading Days following the Put Notice
Date.
“Common
Stock” shall have the meaning set forth in the preamble of this
Agreement.
“Control”
or “Controls” shall have the meaning specified in Section 5(H).
“Effective
Date” shall mean the date the SEC declares effective under the 1933 Act the
Registration Statement covering the Securities.
“Environmental
Laws” shall have the meaning specified in Section 4(M).
“Equity
Line Transaction Documents” shall mean this Agreement, the Registration Rights
Agreement.
“Execution
Date” shall mean the date indicated in the preamble to this
Agreement.
“Indemnities”
shall have the meaning specified in Section 11.
“Indemnified
Liabilities” shall have the meaning specified in Section 11.
“Ineffective
Period” shall mean any period of time that the Registration Statement or any
Supplemental Registration Statement (as defined in the Registration Rights
Agreement between the parties) becomes ineffective or unavailable for use
for
the
sale or resale, as applicable, of any or all of the Registrable Securities
(as
defined in the Registration Rights Agreement) for any reason (or in the event
the prospectus under either of the above is not current and deliverable) during
any time period required under the Registration Rights Agreement.
“Investor”
shall have the meaning indicated in the preamble of this Agreement.
“Material
Adverse Effect” shall have the meaning specified in Section
4(A).
-2-
“Maximum
Common Stock Issuance” shall have the meaning specified in Section
2(H).
“Minimum
Acceptable Price” with respect to any Put Notice Date shall mean seventy-five
percent (75%) of the lowest closing bid prices for the ten (10) Trading Day
period immediately preceding each Put Notice Date.
“Open
Market Adjustment Amount” shall have the meaning specified in Section
2(I).
"Open
Market Purchase" shall have the meaning specified in Section 2(I)
“Open
Market Share Purchase” shall have the meaning specified in Section
2(I).
“Open
Period” shall mean the period beginning on and including the Trading Day
immediately following the Effective Date and ending on the earlier to occur
of
(i)
the date
which is thirty-six (36) months from the Effective Date; or (ii)
termination of the Agreement in accordance with Section 9, below.
“Pricing
Period” shall mean the period beginning on the Put Notice Date and ending on and
including the date that is five (5) Trading Days after such Put Notice
Date.
“Principal
Market” shall mean the American Stock Exchange, Inc., the National Association
of Securities Dealers, Inc. Over-the-Counter Bulletin Board, the NASDAQ National
Market System or the NASDAQ SmallCap Market, whichever is the principal market
on which the Common Stock is listed.
“Prospectus”
shall mean the prospectus, preliminary prospectus and supplemental prospectus
used in connection with the Registration Statement.
“Purchase
Amount” shall mean the total amount being paid by the Investor on a particular
Closing Date to purchase the Securities.
“Purchase
Price” shall mean ninety-three percent (93%) of the lowest closing Best Bid
price of the Common Stock during the Pricing Period.
“Put”
shall have the meaning set forth in Section 2(B)(1) hereof.
“Put
Amount” shall have the meaning set forth in Section 2(B)(1) hereof.
“Put
Notice” shall mean a written notice sent to the Investor by the Company stating
the Put Amount in U.S. dollars the Company intends to sell to the Investor
pursuant to the terms of the Agreement and stating the current number of Shares
issued and outstanding on such date.
-3-
“Put
Notice Date” shall mean the Trading Day, as set forth below, immediately
following the day on which the Investor receives a Put Notice, however a Put
Notice shall be deemed delivered on
(a)
the
Trading Day it is received by facsimile or otherwise by the Investor if such
notice is received prior to 9:00 am Eastern Time, or (b)
the
immediately succeeding Trading Day if it is received by facsimile or otherwise
after 9:00 am Eastern Time on a Trading Day. No Put Notice may be deemed
delivered on a day that is not a Trading Day.
“Put
Restriction” shall mean the days between the beginning of the Pricing Period and
Closing Date. During this time, the Company shall not be entitled to deliver
another Put Notice.
“Put
Shares Due” shall have the meaning specified in Section 2(I).
“Registration
Period” shall have the meaning specified in Section 5(C), below.
“Registration
Rights Agreement” shall have the meaning set forth in the recitals,
above.
“Registration
Statement” means the registration statement of the Company filed under the 1933
Act covering the Common Stock issuable hereunder.
“Related
Party” shall have the meaning specified in Section 5(H).
“Resolution”
shall have the meaning specified in Section 8(E).
“SEC”
shall mean the U.S. Securities & Exchange Commission.
“SEC
Documents” shall have the meaning specified in Section 4(F).
“Securities”
shall mean the shares of Common Stock issued pursuant to the terms of the
Agreement.
“Shares”
shall mean the shares of the Company’s Common Stock.
“Subsidiaries”
shall have the meaning specified in Section 4(A).
“Trading
Day” shall mean any day on which the Principal Market for the Common Stock is
open for trading, from the hours of 9:30 am until 4:00 pm.
-4-
the
Investor shall purchase from the Company, up to that number of Shares having
an
aggregate Purchase Price of Fifty Million dollars ($50,000,000).
(I)
Subject to the terms and conditions of the Equity Line Transaction Documents,
and from time to time during the Open Period, the Company may, in its sole
discretion, deliver a Put Notice to the Investor which states the dollar amount
(designated in U.S. Dollars) (the "Put Amount"), which the Company intends
to
sell to the Investor on a Closing Date (the "Put"). The Put Notice shall be
in
the form attached hereto as Exhibit C and incorporated herein by reference.
The
amount that the Company shall be entitled to Put to the Investor (the "Put
Amount") shall be equal to, at the Company's election, either: (A) Two Hundred
percent (200%) of the average daily volume (U.S. market only) of the Common
Stock for the Ten (10) Trading Days prior to the applicable Put Notice Date,
multiplied by the average of the three (3) daily closing bid prices immediately
preceding the Put Date, or (B) two hundred fifty thousand dollars ($250,000).
During the Open Period, the Company shall not be entitled to submit a Put Notice
until after the previous Closing has been completed. The Purchase Price for
the
Common Stock identified in the Put Notice shall be equal to ninety-three percent
(93%) of the lowest closing Best Bid price of the Common Stock during the
Pricing Period.
(I)
a
Registration Statement shall have been declared effective and shall remain
effective and available for the resale of all the Registrable Securities (as
defined in the Registration Rights Agreement) at all times until the Closing
with respect to the subject Put Notice;
(II)
at
all times during the period beginning on the related Put Notice Date and ending
on and including the related Closing Date, the Common Stock shall have been
listed on the Principal Market and shall not have been suspended from trading
thereon for a period of two (2) consecutive Trading Days during
the
-5-
Open
Period and the Company shall not have been notified of any pending or threatened
proceeding or other action to suspend the trading of the Common Stock;
(III)
the
Company has complied with its obligations and is otherwise not in breach of
or
in default under, this Agreement, the Registration Rights Agreement or any
other
agreement executed in connection herewith which has not been cured prior to
delivery of the Investor’s Put Notice Date;
(IV)
no
injunction shall have been issued and remain in force, or action commenced
by a
governmental authority which has not been stayed or abandoned, prohibiting
the
purchase or the issuance of the Securities; and
(V)
the
issuance of the Securities will not violate any shareholder approval
requirements of the Principal Market.
If
any of
the events described in clauses (I) through (V) above occurs during a Pricing
Period, then the Investor shall have no obligation to purchase the Put Amount
of
Common Stock set forth in the applicable Put Notice.
(F)
RESERVED
The
Company understands that a delay in the issuance of Securities beyond the
Closing Date could result in economic damage to the Investor. After the
Effective Date, as compensation to the Investor for such loss, the Company
agrees to make late payments to the Investor for late issuance of Securities
(delivery of Securities after the applicable Closing Date) in accordance with
the following schedule (where "No. of Days Late" is defined as the number of
trading days beyond the Closing Date, with the Amounts being
cumulative.):
LATE
PAYMENT FOR EACH
|
||||
NO.
OF DAYS LATE
|
$10,000
WORTH OF COMMON STOCK
|
|||
1
|
$
|
100
|
||
2
|
$
|
200
|
||
3
|
$
|
300
|
||
4
|
$
|
400
|
||
5
|
$
|
500
|
||
6
|
$
|
600
|
||
7
|
$
|
700
|
||
8
|
$
|
800
|
||
9
|
$
|
900
|
||
10
|
$
|
1,000
|
||
Over
10
|
$
|
1,000
+ $200 for each Business Day late beyond 10 days
|
The
Company shall make any payments incurred under this Section in immediately
available funds upon demand by the Investor. Nothing herein shall limit the
Investor's right to pursue actual damages for the Company's failure to issue
and
deliver the Securities to the Investor, except that such late payments shall
offset any such actual damages incurred by the Investor, and any Open Market
Adjustment Amount, as set forth below.
(I)
If,
by the third (3rd) business day after the Closing Date, the Company fails to
deliver any portion of the shares of the Put to the Investor (the "Put Shares
Due") and the Investor purchases, in an open market transaction or otherwise,
shares of Common Stock necessary to make delivery of shares which would have
been delivered if the full amount of the shares to be delivered to the Investor
by the Company (the "Open Market Share Purchase") , then the Company shall
pay
to the Investor, in addition to any other amounts due to Investor pursuant
to
the Put,
-6-
and
not
in lieu thereof, the Open Market Adjustment Amount (as defined below). The
"Open
Market Adjustment Amount" is the amount equal to the excess, if any, of (x)
the
Investor's total purchase price (including brokerage commissions, if any) for
the Open Market Share Purchase minus (y) the net proceeds (after brokerage
commissions, if any) received by the Investor from the sale of the Put Shares
Due. The Company shall pay the Open Market Adjustment Amount to the Investor
in
immediately available funds within five (5) business days of written demand
by
the Investor. By way of illustration and not in limitation of the foregoing,
if
the Investor purchases shares of Common Stock having a total purchase price
(including brokerage commissions) of $11,000 to cover an Open Market Purchase
with respect to shares of Common Stock it sold for net proceeds of $10,000,
the
Open Market Purchase Adjustment Amount which the Company will be required to
pay
to the Investor will be $1,000.
The
Investor represents and warrants to the Company, and covenants, that:
(A)
SOPHISTICATED INVESTOR. The Investor has, by reason of its business and
financial experience, such knowledge, sophistication and experience in financial
and business matters and in making investment decisions of this type that it
is
capable of (I) evaluating the merits and risks of an investment in the
Securities and making an informed investment decision; (II) protecting its
own
interest; and (III) bearing the economic risk of such investment for an
indefinite period of time.
(C)
SECTION 9 OF THE 1934 ACT. During the term of this Agreement, the Investor
will
comply with the provisions of Section 9 of the 1934 Act, and the rules
promulgated thereunder, with respect to transactions involving the Common Stock.
The Investor agrees not to sell the Company's stock short, either
directly
-7-
or
indirectly through its affiliates, principals or advisors, the Company's common
stock during the term of this Agreement.
(D)
ACCREDITED INVESTOR. Investor is an "Accredited Investor" as that term is
defined in Rule 501(a) of Regulation D of the 1933 Act.
(H)
NO
REGISTRATION AS A DEALER. The Investor is not and will not be required to be
registered as a "dealer" under the 1934 Act, either as a result of its execution
and performance of its obligations under this Agreement or otherwise.
(K)
REGULATION M. The Investor will comply with Regulation M under the 1934 Act,
if
applicable.
Except
as
set forth in the Schedules attached hereto, or as disclosed on the Company's
SEC
Documents, the Company represents and warrants to the Investor that:
-8-
qualified
to do business and are in good standing in every jurisdiction in which its
ownership of property or the nature of the business conducted by it makes such
qualification necessary, except to the extent that the failure to be so
qualified or be in good standing would not have a Material Adverse Effect.
As
used in this Agreement, "Material Adverse Effect" means any material adverse
effect on the business, properties, assets, operations, results of operations,
financial condition or prospects of the Company and its Subsidiaries, if any,
taken as a whole, or on the transactions contemplated hereby or by the
agreements and instruments to be entered into in connection herewith, or on
the
authority or ability of the Company to perform its obligations under the Equity
Line Transaction Documents (as defined in Section 1 and 4(B), below).
(I)
The
Company has the requisite corporate power and authority to enter into and
perform this Investment Agreement and the Registration Rights Agreement
(collectively, the "Equity Line Transaction Documents"), and to issue the
Securities in accordance with the terms hereof and thereof.
(II)
The
execution and delivery of the Equity Line Transaction Documents by the Company
and the consummation by it of the transactions contemplated hereby and thereby,
including without limitation the reservation for issuance and the issuance
of
the Securities pursuant to this Agreement, have been duly and validly authorized
by the Company's Board of Directors and no further consent or authorization
is
required by the Company, its Board of Directors, or its shareholders.
(III)
The
Equity Line Transaction Documents have been duly and validly executed and
delivered by the Company.
(IV)
The
Equity Line Transaction Documents constitute the valid and binding obligations
of the Company enforceable against the Company in accordance with their terms,
except as such enforceability may be limited by general principles of equity
or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
or
similar laws relating to, or affecting generally, the enforcement of creditors'
rights and remedies.
(C)
CAPITALIZATION. As of the date hereof, the authorized capital stock of the
Company consists of 98,800,000 shares of Common Stock, $.0001 par value per
share, of which as of the date hereof
11,077,922
shares
are issued and outstanding; 1,200,000 shares of Preferred Stock authorized
with
no shares issued or outstanding; as of July 31, 2007, and 31,615,000
shares
(as
described in further detail below)
reserved
for issuance pursuant to options, warrants and other convertible securities.
The
Company has issued $1.5 million and $3.9 million of convertible notes (the
“Convertible Notes”) to three private investors (the “Private Investors”) which
are convertible into common shares of the
-9-
Company
at discounted rates making the number of shares subject to conversion impossible
to calculate with precision. The Private Investors were also issued warrants
to
purchase 10,000,000 shares of common stock. The Company has reserved 21,615,000
shares of common stock for issuance to the Private Investors under the
Convertible Notes and 10,000,000 shares for issuance under the warrants.
All
of
such outstanding shares have been, or upon issuance will be, validly issued
and
are fully paid and nonassessable.
Except
as
disclosed in this
Agreement, as provided for in the Company’s agreements with the Private
Investors, and in the
Company's publicly available filings with the SEC:
(I)
no
shares of the Company's capital stock are subject to preemptive rights or any
other similar rights or any liens or encumbrances suffered or permitted by
the
Company; (II) there are no outstanding debt securities; (III) there are no
outstanding shares of capital stock, options, warrants, scrip, rights to
subscribe to, calls or commitments of any character whatsoever relating to,
or
securities or rights convertible into, any shares of capital stock of the
Company or any of its Subsidiaries, or contracts, commitments, understandings
or
arrangements by which the Company or any of its Subsidiaries is or may become
bound to issue additional shares of capital stock of the Company or any of
its
Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any of its
Subsidiaries; (IV) there are no agreements or arrangements under which the
Company or any of its Subsidiaries is obligated to register the sale of any
of
their securities under the 1933 Act (except the Registration Rights Agreement);
(V) there are no outstanding securities of the Company or any of its
Subsidiaries which contain any redemption or similar provisions, and there
are
no contracts, commitments, understandings or arrangements by which the Company
or any of its Subsidiaries is or may become bound to redeem a security of the
Company or any of its Subsidiaries; (VI) there are no securities or instruments
containing anti-dilution or similar provisions that will be triggered by the
issuance of the Securities as described in this Agreement; (VII) the Company
does not have any stock appreciation rights or "phantom stock" plans or
agreements or any similar plan or agreement; and (VIII) there is no dispute
as
to the classification of any shares of the Company's capital stock.
The
Company has furnished to the Investor, or the Investor has had access through
XXXXX to, true and correct copies of the Company's Amended and Restated
Certificate of Incorporation, as in effect on the date hereof (the "Certificate
of Incorporation"), and the Company's By-laws, as in effect on the date hereof
(the "By-laws"), and the terms of all securities convertible into or exercisable
for Common Stock and the material rights of the holders thereof in respect
thereto.
-10-
(D)
ISSUANCE OF SHARES. The Company has reserved 20,000,000
Shares
for issuance pursuant to this Agreement, which have been duly authorized and
reserved those Shares for issuance (subject to adjustment pursuant to the
Company's covenant set forth in Section 5(F) below) pursuant to this Agreement.
Upon issuance in accordance with this Agreement, the Securities will be validly
issued, fully paid for and non-assessable and free from all taxes, liens and
charges with respect to the issue thereof. In the event the Company cannot
register a sufficient number of Shares for issuance pursuant to this Agreement,
the Company will use its best efforts to authorize and reserve for issuance
the
number of Shares required for the Company to perform its obligations hereunder
as soon as reasonably practicable.
-11-
Registration
Rights Agreement between the Parties) with, any court, governmental authority
or
agency, regulatory or self-regulatory agency or other third party in order
for
it to execute, deliver or perform any of its obligations under, or contemplated
by, the Equity Line Transaction Documents in accordance with the terms hereof
or
thereof. All consents, authorizations, permits, orders, filings and
registrations which the Company is required to obtain pursuant to the preceding
sentence have been obtained or effected on or prior to the date hereof and
are
in full force and effect as of the date hereof. Except as disclosed in Schedule
4(e), the Company and its Subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing. The Company is not, and will
not
be, in violation of the listing requirements of the Principal Market as in
effect on the date hereof and on each of the Closing Dates and is not aware
of
any facts which would reasonably lead to delisting of the Common Stock by the
Principal Market in the foreseeable future.
(F)
SEC
DOCUMENTS; FINANCIAL STATEMENTS. As of the date hereof, the Company has filed
all reports, schedules, forms, statements and other documents required to be
filed by it with the SEC pursuant to the reporting requirements of the 1934
Act
(all of the foregoing filed prior to the date hereof and all exhibits included
therein and financial statements and schedules thereto and documents
incorporated by reference therein being hereinafter referred to as the "SEC
Documents"). The Company has delivered to the Investor or its representatives,
or they have had access through XXXXX to, true and complete copies of the SEC
Documents. As of their respective filing dates, the SEC Documents complied
in
all material respects with the requirements of the 1934 Act and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC Documents,
and none of the SEC Documents, at the time they were filed with the SEC,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading. As
of
their respective dates, the financial statements of the Company included in
the
SEC Documents complied as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC
with
respect thereto. Such financial statements have been prepared in accordance
with
generally accepted accounting principles, by a firm that is a member of the
Public Companies Accounting Oversight Board ("PCAOB") consistently applied,
during the periods involved (except (I) as may be otherwise indicated in such
financial statements or the notes thereto, or (II) in the case of unaudited
interim statements, to the extent they may exclude footnotes or may be condensed
or summary statements) and fairly present in all material respects the financial
position of the Company as of the dates thereof and the results of its
operations and cash flows for the periods then ended (subject, in the case
of
unaudited statements, to normal year-end audit adjustments). No other written
information provided by or on behalf of the Company to the Investor which is
not
included in the SEC Documents, including, without limitation, information
referred to in Section 4(D) of this Agreement, contains any untrue statement
of
a material fact or omits to state any material
-12-
fact
necessary to make the statements therein, in the light of the circumstance
under
which they are or were made, not misleading. Neither the Company nor any of
its
Subsidiaries or any of their officers, directors, employees or agents have
provided the Investor with any material, nonpublic information which was not
publicly disclosed prior to the date hereof and any material, nonpublic
information provided to the Investor by the Company or its Subsidiaries or
any
of their officers, directors, employees or agents prior to any Closing Date
shall be publicly disclosed by the Company prior to such Closing
Date.
(G)
ABSENCE OF CERTAIN CHANGES. Except as otherwise set forth in the SEC
Documents,
or as
publicly announced over the past 10 days,
the
Company does not intend to change the business operations of the Company in
any
material way. The Company has not taken any steps, and does not currently expect
to take any steps, to seek protection pursuant to any bankruptcy law nor does
the Company or its Subsidiaries have any knowledge or reason to believe that
its
creditors intend to initiate involuntary bankruptcy proceedings.
(H)
ABSENCE OF LITIGATION AND/OR REGULATORY PROCEEDINGS. Except as set forth in
the
SEC Documents, there is no action, suit, proceeding, inquiry or investigation
before or by any court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the executive officers
of
Company or any of its Subsidiaries, threatened against or affecting the Company,
the Common Stock or any of the Company's Subsidiaries or any of the Company's
or
the Company's Subsidiaries' officers or directors in their capacities as such,
in which an adverse decision could have a Material Adverse Effect.
(I)
ACKNOWLEDGMENT REGARDING INVESTOR'S PURCHASE OF SHARES. The Company acknowledges
and agrees that the Investor is acting solely in the capacity of an arm's length
purchaser with respect to the Transaction Documents and the transactions
contemplated hereby and thereby. The Company further acknowledges that the
Investor is not acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to the Equity Line Transaction Documents
and
the transactions contemplated hereby and thereby and any advice given by the
Investor or any of its respective representatives or agents in connection with
the Equity Line Transaction Documents and the transactions contemplated hereby
and thereby is merely incidental to the Investor's purchase of the Securities,
and is not being relied on by the Company. The Company further represents to
the
Investor that the Company's decision to enter into the Equity Line Transaction
Documents has been based solely on the independent evaluation by the Company
and
its representatives.
(J)
NO
UNDISCLOSED EVENTS, LIABILITIES, DEVELOPMENTS OR CIRCUMSTANCES. Except as set
forth in the SEC Documents, as of the date hereof, no event, liability,
development or circumstance has occurred or exists, or to the Company's
knowledge is contemplated to occur, with respect to the
-13-
Company
or its Subsidiaries or their respective business, properties, assets, prospects,
operations or financial condition, that would be required to be disclosed by
the
Company under applicable securities laws on a registration statement filed
with
the SEC relating to an issuance and sale by the Company of its Common
Stock which
has
not been publicly announced.
(M)
ENVIRONMENTAL LAWS. The Company and its Subsidiaries (I) are, to the knowledge
of the management and directors of the Company and its Subsidiaries, in
compliance with any and all applicable foreign, federal, state and local laws
and regulations relating to the protection of human health and safety, the
environment or hazardous or toxic substances or wastes, pollutants
or
-14-
contaminants
("Environmental Laws"); (II) have, to the knowledge of the management and
directors of the Company, received all permits, licenses or other approvals
required of them under applicable Environmental Laws to conduct their respective
businesses; and (III) are in compliance, to the knowledge of the management
and
directors of the Company, with all terms and conditions of any such permit,
license or approval where, in each of the three (3) foregoing cases, the failure
to so comply would have, individually or in the aggregate, a Material Adverse
Effect.
(Q)
INTERNAL ACCOUNTING CONTROLS. The Company and each of its
Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable
assurance that (I) transactions are executed in accordance with management's
general or specific authorizations; (II) transactions are
-15-
recorded
as necessary to permit preparation of financial statements in conformity with
generally accepted accounting principles by a firm with membership to the PCAOB
and to maintain asset accountability; (III) access to assets is permitted only
in accordance with management's general or specific authorization; and (IV)
the
recorded accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences.
(T)
CERTAIN TRANSACTIONS. Except as set forth in the SEC Documents filed at least
ten (10) days prior to the date hereof and except for arm's length transactions
pursuant to which the Company makes payments in the ordinary course of business
upon terms no less favorable than the Company could obtain from disinterested
third parties
such as
the Company’s recent acquisition of the operating assets of Lextra Management
Group, Inc.,
and
other than the grant of stock options disclosed in the SEC Documents, none
of
the officers, directors, or employees of the Company is presently a party to
any
transaction with the Company or any of its Subsidiaries (other than for services
as employees, officers and directors), including any contract, agreement or
other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, or otherwise requiring
payments to or from any officer, director or such employee or, to the knowledge
of the Company, any corporation, partnership, trust or other entity in which
any
officer, director, or any such employee has a substantial interest or is an
officer, director, trustee or partner.
-16-
(U)
DILUTIVE EFFECT. The Company understands and acknowledges that the number of
shares of Common Stock issuable upon purchases pursuant to this Agreement will
increase in certain circumstances including, but not necessarily limited to,
the
circumstance wherein the trading price of the Common Stock declines during
the
period between the Effective Date and the end of the Open Period. The Company's
executive officers and directors have studied and fully understand the nature
of
the transactions contemplated by this Agreement and recognize that they have
a
potential dilutive effect on the shareholders of the Company. The Board of
Directors of the Company has concluded, in its good faith business judgment,
and
with full understanding of the implications, that such issuance is in the best
interests of the Company. The Company specifically acknowledges that, subject
to
such limitations as are expressly set forth in the Equity Line Transaction
Documents, its obligation to issue shares of Common Stock upon purchases
pursuant to this Agreement is absolute and unconditional regardless of the
dilutive effect that such issuance may have on the ownership interests of other
shareholders of the Company.
(X)
NO
BROKERS, FINDERS OR FINANCIAL ADVISORY FEES OR COMMISSIONS. No brokers, finders
or financial advisory fees or commissions will be payable by the Company, its
agents or Subsidiaries, with respect to the transactions contemplated by this
Agreement, except as otherwise disclosed in this Agreement.
(A)
BEST
EFFORTS. The Company shall use all commercially reasonable efforts to timely
satisfy each of the conditions set forth in Section 7 of this Agreement.
-17-
(C)
REPORTING STATUS. Until one of the following occurs, the Company shall file
all
reports required to be filed with the SEC pursuant to the 1934 Act, and the
Company shall not terminate its status, or take an action or fail to take any
action, which would terminate its status as a reporting company under the 1934
Act: (i) this Agreement terminates pursuant to Section 9 and the Investor has
the right to sell all of the Securities without restrictions pursuant to Rule
144(k) promulgated under the 1933 Act, or such other exemption (ii) the date
on
which the Investor has sold all the Securities and this Agreement has been
terminated pursuant to Section 9.
-18-
Equity
Line Transaction Documents. Neither the Company nor any of its Subsidiaries
shall take any action which would be reasonably expected to result in the
delisting or suspension of the Common Stock on the Principal Market (excluding
suspensions of not more than one (1) trading day resulting from business
announcements by the Company). The Company shall promptly provide to the
Investor copies of any notices it receives from the Principal Market regarding
the continued eligibility of the Common Stock for listing on such automated
quotation system or securities exchange. The Company shall pay all fees and
expenses in connection with satisfying its obligations under this Section 5(G).
(I)
FILING OF FORM 8-K. On or before the date which is four (4) Trading Days after
the Execution Date, the Company shall file a Current Report on Form 8-K with
the
SEC describing the terms of the transaction contemplated by the Equity Line
Transaction Documents in the form required by the 1934 Act, if such filing
is
required.
-19-
(L)
REIMBURSEMENT. If (I) the Investor becomes involved in any capacity in any
action, proceeding or investigation brought by any shareholder of the Company,
in connection with or as a result of the consummation of the transactions
contemplated by the Equity Line Transaction Documents, or if the Investor is
impleaded in any such action, proceeding or investigation by any person (other
than as a result of a breach of the Investor’s representations and warranties
set forth in this Agreement); or (II) the Investor becomes involved in any
capacity in any action, proceeding or investigation brought by the SEC against
or involving the Company or in connection with or as a result of the
consummation of the transactions contemplated by the Equity Line Transaction
Documents (other than as a result of a breach of the Investor’s representations
and warranties set forth in this Agreement),
or if
this Investor is impleaded in any such action, proceeding or investigation
by
any person, then in any such case, the Company will reimburse the Investor
for
its reasonable legal and other expenses (including the cost of any investigation
and preparation) incurred in connection therewith, as such expenses are
incurred. In addition, other than with respect to any matter in which the
Investor is a named party, the Company will
-20-
pay
to
the Investor the charges, as reasonably determined by the Investor, for the
time
of any officers or employees of the Investor devoted to appearing and preparing
to appear as witnesses
at per
diem rates,
assisting in preparation for hearings, trials or pretrial matters, or otherwise
with respect to inquiries, hearing, trials, and other proceedings relating
to
the subject matter of this Agreement. The reimbursement obligations of the
Company under this section shall be in addition to any liability which the
Company may otherwise have, shall extend upon the same terms and conditions
to
any affiliates of the Investor that are actually named in such action,
proceeding or investigation, and partners, directors, agents, employees,
attorneys, accountants, auditors and controlling persons (if any), as the case
may be, of Investor and any such affiliate, and shall be binding upon and inure
to the benefit of any successors of the Company, the Investor and any such
affiliate and any such person.
The
obligation hereunder of the Company to issue and sell the Securities to the
Investor is further subject to the satisfaction, at or before each Closing
Date,
of each of the following conditions set forth below. These conditions are for
the Company's sole benefit and may be waived by the Company at any time in
its
sole discretion.
(A)
The
Investor shall have executed this Agreement and the Registration Rights
Agreement and delivered the same to the Company.
(B)
The
Investor shall have delivered to the Company the Purchase Price for the
Securities being purchased by the Investor between the end of the Pricing Period
and the Closing Date via a Put Settlement Sheet (hereto attached as Exhibit
D).
After receipt of confirmation of delivery of such Securities to the Investor,
the Investor, by wire transfer of immediately available funds pursuant to the
wire instructions provided by the Company will disburse the funds constituting
the Purchase Amount.
-21-
(C)
No
statute, rule, regulation, executive order, decree, ruling or injunction shall
have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction which prohibits the consummation of any
of
the transactions contemplated by this Agreement.
The
obligation of the Investor hereunder to purchase Shares is subject to the
satisfaction, on or before each Closing Date, of each of the following
conditions set forth below.
(A)
The
Company shall have executed the Equity Line Transaction Documents and delivered
the same to the Investor.
(B)
The
Common Stock shall be authorized for quotation on the Principal Market and
trading in the Common Stock shall not have been suspended by the Principal
Market or the SEC, at any time beginning on the date hereof and through and
including the respective Closing Date (excluding suspensions of not more than
one (1) Trading Day resulting from business announcements by the Company,
provided that such suspensions occur prior to the Company's delivery of the
Put
Notice related to such Closing).
(C)
The
representations and warranties of the Company shall be true and correct as
of
the date when made and as of the applicable Closing Date as though made at
that
time and the Company shall have performed, satisfied and complied with the
covenants, agreements and conditions required by the Equity Line Transaction
Documents to be performed, satisfied or complied with by the Company on or
before such Closing Date. The Investor may request an update as of such Closing
Date regarding the representation contained in Section 4(C) above.
(D)
The
Company shall have executed and delivered to the Investor the certificates
representing, or have executed electronic book-entry transfer of, the Securities
(in such denominations as the Investor shall request) being purchased by the
Investor at such Closing.
(E)
The
Board of Directors of the Company shall have adopted resolutions consistent
with
Section 4(B)(II) above (the "Resolutions") and such Resolutions shall not have
been amended or rescinded prior to such Closing Date.
(G)
No
statute, rule, regulation, executive order, decree, ruling or injunction shall
have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction which prohibits the consummation of any
of
the transactions contemplated by this Agreement.
-22-
(H)
The
Registration Statement shall be effective on each Closing Date and no stop
order
suspending the effectiveness of the Registration statement shall be in effect
or
to the Company's knowledge shall be pending or threatened. Furthermore, on
each
Closing Date (I) neither the Company nor the Investor shall have received notice
that the SEC has issued or intends to issue a stop order with respect to such
Registration Statement or that the SEC otherwise has suspended or withdrawn
the
effectiveness of such Registration Statement, either temporarily or permanently,
or intends or has threatened to do so (unless the SEC's concerns have been
addressed and Investor is reasonably satisfied that the SEC no longer is
considering or intends to take such action), and (II) no other suspension of
the
use or withdrawal of the effectiveness of such Registration Statement or related
prospectus shall exist.
(I)
At
the time of each Closing, the Registration Statement (including information
or
documents incorporated by reference therein) and any amendments or supplements
thereto shall not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make
the
statements therein not misleading or which would require public disclosure
or an
update supplement to the prospectus.
(J)
If
applicable, the shareholders of the Company shall have approved the issuance
of
any Shares in excess of the Maximum Common Stock Issuance in accordance with
Section 2(H) or the Company shall have obtained appropriate approval pursuant
to
the requirements of Delaware law and the Company’s Articles of Incorporation and
By-laws.
(K)
The
conditions to such Closing set forth in Section 2(E) shall have been satisfied
on or before such Closing Date.
(L)
The
Company shall have certified to the Investor the number of Shares of Common
Stock outstanding when a Put Notice is given to the Investor. The Company's
delivery of a Put Notice to the Investor constitutes the Company's certification
of the existence of the necessary number of shares of Common Stock reserved
for
issuance.
(I)
when
the Investor has purchased an aggregate of Fifty Million dollars ($50,000,000)
in the Common Stock of the Company pursuant to this Agreement; or,
(II)
on
the date which is thirty-six (36) months after the Effective Date;
or,
(III)
upon written notice of the Company to the Investor. Any and all shares, or
penalties, if any, due under this Agreement shall be immediately payable and
due
upon termination of the Line.
-23-
This
Agreement shall be suspended upon any of the following events, and shall remain
suspended until such event is rectified:
(I)
the
trading of the Common Stock is suspended by the SEC, the Principal Market or
the
NASD for a period of two (2) consecutive Trading Days during the Open Period;
or,
(II)
The
Common Stock ceases to be registered under the 1934 Act or listed or traded
on
the Principal Market. Immediately upon the occurrence of one of the
above-described events, the Company shall send written notice of such event
to
the Investor.
In
consideration of the parties mutual obligations set forth in the Transaction
Documents, each of the parties (in such capacity, an "Indemnitor") shall defend,
protect, indemnify and hold harmless the other and all of the other party's
shareholders, officers, directors, employees, counsel, and direct or indirect
investors and any of the foregoing person's agents or other representatives
(including, without limitation, those retained in connection with the
transactions contemplated by this Agreement) (collectively, the "Indemnitees")
from and against any and all actions, causes of action, suits, claims, losses,
costs, penalties, fees, liabilities and damages, and reasonable expenses in
connection therewith (irrespective of whether any such Indemnitee is a party
to
the action for which indemnification hereunder is sought), and including
reasonable attorneys' fees and disbursements (the "Indemnified Liabilities"),
incurred by any Indemnitee as a result of, or arising out of, or relating to
(I)
any misrepresentation or breach of any representation or warranty made by the
Indemnitor or any other certificate, instrument or document contemplated hereby
or thereby; (II) any breach of any covenant, agreement or obligation of the
Indemnitor contained in the Equity Line Transaction Documents or any other
certificate, instrument or document contemplated hereby or thereby; or (III)
any
cause of action, suit or claim brought or made against such Indemnitee by a
third party and arising out of or resulting from the execution, delivery,
performance or enforcement of the Equity Line Transaction Documents or any
other
certificate, instrument or document contemplated hereby or thereby, except
insofar as any such misrepresentation, breach or any untrue statement, alleged
untrue statement, omission or alleged omission is made in reliance upon and
in
conformity with information furnished to Indemnitor which is specifically
intended for use in the preparation of any such Registration Statement,
preliminary prospectus, prospectus or amendments to the prospectus. To the
extent that the foregoing undertaking by the Indemnitor may be unenforceable
for
any reason, the Indemnitor shall make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities which is permissible
under applicable law.
-24-
The
indemnity provisions contained herein shall be in addition to any cause of
action or similar rights Indemnitor may have, and any liabilities the Indemnitor
or the Indemnitees may be subject to.
All
disputes arising under this agreement shall be governed by and interpreted
in
accordance with the laws of the Commonwealth of Massachusetts, without regard
to
principles of conflict of laws. The parties to this agreement will submit all
disputes arising under this agreement to arbitration in Boston, Massachusetts
before a single arbitrator of the American Arbitration Association (“AAA”). The
arbitrator shall be selected by application of the rules of the AAA, or by
mutual agreement of the parties, except that such arbitrator shall be an
attorney admitted to practice law in the Commonwealth of Massachusetts. No
party
to this agreement will challenge the jurisdiction or venue provisions as
provided in this section. No party to this agreement will challenge the
jurisdiction or venue provisions as provided in this section. Nothing contained
herein shall prevent the party from obtaining an injunction.
(B)
LEGAL
FEES; AND MISCELLANEOUS FEES. Except as otherwise set forth in the Equity Line
Transaction Documents, each party shall pay the fees and expenses of its
advisers, counsel, the accountants and other experts, if any, and all other
expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. Any attorneys' fees
and
expenses incurred by either the Company or the Investor in connection with
the
preparation, negotiation, execution and delivery of any amendments to this
Agreement or relating to the enforcement of the rights of any party, after
the
occurrence of any breach of the terms of this Agreement by another party or
any
default by another party in respect of the transactions contemplated hereunder,
shall be paid on demand by the party which breached the Agreement and/or
defaulted, as the case may be. The Company shall pay all stamp and other taxes
and duties levied in connection with the issuance of any Securities.
(D)
HEADINGS; SINGULAR/PLURAL. The headings of this Agreement are for convenience
of
reference and shall not form part of, or affect the interpretation of, this
Agreement. Whenever required by the context of this Agreement, the singular
shall include the plural and masculine shall include the feminine.
-25-
If
to the Company:
000
Xxxxxxxxxxxxx Xxxxxxx, 0xx
xxxxx
Xxxx
Xxxx, XX 00000
Telephone:
(000) 000-0000
Facsimile:
With
a
copy to:
Xxxxxxxx
Xxxxxx
000
Xxxxxxx Xxxx Xxxxxx, Xxxxx 0000
Xxxxxxxx
Xxxxx, XX 00000
Attention:
Xxxx X. Xxxxx Xx.
Telephone:
(000) 000-0000
Facsimile:
(000) 000-0000
-26-
If
to the Investor:
Dutchess
Private Equities Fund, Ltd.,
00
Xxxxxxxxxxxx Xxxxxx, Xxxxx 0
Xxxxxx,
XX 00000
Telephone:
000-000-0000
Facsimile:
000-000-0000
Each
party shall provide five (5) days prior written notice to the other party of
any
change in address or facsimile number.
(H)
NO
ASSIGNMENT. This Agreement may not be assigned.
(I)
NO
THIRD PARTY BENEFICIARIES. This Agreement is intended for the benefit of the
parties hereto and is not for the benefit of, nor may any provision hereof
be
enforced by, any other person, except that the Company acknowledges that the
rights of the Investor may be enforced by its general partner.
-27-
-28-
(a)
The
Company shall not disclose non-public information to the Investor, its advisors,
or its representatives.
(b)
Nothing herein shall require the Company to disclose non-public information
to
the Investor or its advisors or representatives, and the Company represents
that
it does not disseminate non-public information to any investors who purchase
stock in the Company in a public offering, to money managers or to securities
analysts, provided, however, that notwithstanding anything herein to the
contrary, the Company will, as hereinabove provided, immediately notify the
advisors and representatives of the Investor and, if any, underwriters, of
any
event or the existence of any circumstance (without any obligation to disclose
the specific event or circumstance) of which it becomes aware, constituting
non-public information (whether or not requested of the Company specifically
or
generally during the course of due diligence by such persons or entities),
which, if not disclosed in the prospectus included in the Registration Statement
would cause such prospectus to include a material misstatement or to omit a
material fact required to be stated therein in order to make the statements,
therein, in light of the circumstances in which they were made, not misleading.
Nothing contained in this Section 13 shall be construed to mean that such
persons or entities other than the Investor (without the written consent of
the
Investor prior to disclosure of such information) may not obtain non-public
information in the course of conducting due diligence in accordance with the
terms of this Agreement and nothing herein shall prevent any such persons or
entities from notifying the Company of their opinion that based on such due
diligence by such persons or entities, that the Registration Statement contains
an untrue statement of material fact or omits a material fact required to be
stated in the Registration Statement or necessary to make the statements
contained therein, in light of the circumstances in which they were made, not
misleading.
Notwithstanding
anything in this Agreement to the contrary, the parties hereto hereby
acknowledge and agree to the following: (i) the Investor makes no
representations or covenants that it will not engage in trading in the
securities of the Company, other than the Investor will not sell short the
Company's common stock at any time during this Agreement; (ii) the Company
shall, by 8:30 a.m. Boston Time on the trading day following the date hereof,
file a current report on Form 8-K disclosing the material terms of the
transactions contemplated hereby and in the other Equity Line Transaction
Documents; (iii) the Company has not and shall not provide material non-public
information to the Investor unless prior thereto the Investor shall have
executed a written agreement regarding the confidentiality and use of such
information; and (iv) the Company understands and confirms that the Investor
will be relying on the acknowledgements set forth in clauses (i) through (iii)
above if the Investor effects any transactions in the securities of the Company.
-29-
SIGNATURE
PAGE OF INVESTMENT AGREEMENT
Your
signature on this Signature Page evidences your agreement to be bound by the
terms and conditions of the Investment Agreement and the Registration Rights
Agreement as of the date first written above.
The
undersigned signatory hereby certifies that he has read and understands the
Investment Agreement, and the representations made by the undersigned in this
Investment Agreement are true and accurate, and agrees to be bound by its terms.
DUTCHESS
PRIVATE EQUITIES FUND, LTD.
By:____________________________
Xxxxxxx
X. Xxxxxxxx, Director
By:__________________________________
Xxx
Xxxxxx Xxxx, CEO
-30-
LIST
OF EXHIBITS
EXHIBIT
A Registration Rights Agreement
EXHIBIT
B Opinion of Company's Counsel
EXHIBIT
C Put Notice
EXHIBIT
D Put Settlement Sheet
|
-31-
EXHIBIT
A
-32-
EXHIBIT
B
FORM
OF
NOTICE OF EFFECTIVENESS
OF
REGISTRATION STATEMENT
Date:
__________
[TRANSFER
AGENT]
Ladies
and Gentlemen:
We
are
counsel to SportsQuest, Inc., a Delaware corporation (the "Company"), and have
represented the Company in connection with that certain Investment Agreement
(the "Investment Agreement") entered into by and among the Company and
_________________________ (the "Investor") pursuant to which the Company has
agreed to issue to the Investor shares of the Company's common stock, $.0001
par
value per share (the "Common Stock") on the terms and conditions set forth
in
the Investment Agreement. Pursuant to the Investment Agreement, the Company
also
has entered into a Registration Rights Agreement with the Investor (the
"Registration Rights Agreement") pursuant to which the Company agreed, among
other things, to register the Registrable Securities (as defined in the
Registration Rights Agreement), including the shares of Common Stock issued
or
issuable under the Investment Agreement under the Securities Act of 1933, as
amended (the "1933 Act"). In connection with the Company's obligations under
the
Registration Rights Agreement, on ____________ ___, 2006, the Company filed
a
Registration Statement on Form S- ___ (File No. 333-________) (the "Registration
Statement") with the Securities and Exchange Commission (the "SEC") relating
to
the Registrable Securities which names the Investor as a selling shareholder
thereunder.
In
connection with the foregoing, we advise you that [a
member
of the SEC's staff has advised us by telephone that the SEC has entered an
order
declaring the Registration Statement effective]
[the
Registration Statement has become effective]
under
the 1933 Act at [enter the time of effectiveness] on [enter the date of
effectiveness] and to the best of our knowledge, after telephonic inquiry of
a
member of the SEC’s staff, no stop order suspending its effectiveness has been
issued and no proceedings for that purpose are pending before, or threatened
by,
the SEC and the Registrable Securities are available for resale under the 1933
Act pursuant to the Registration Statement.
Very
truly yours,
[Company
Counsel]
-33-
EXHIBIT
C
Date:
RE:
Put
Notice Number __
Dear
Xx.
Xxxxxxxx,
This
is
to inform you that as of today, SportsQuest, Inc., a Delaware corporation (the
"Company"), hereby elects to exercise its right pursuant to the Investment
Agreement to require Dutchess Private Equities Fund, Ltd. to purchase shares
of
its common stock. The Company hereby certifies that:
The
amount of this put is $__________.
The
Pricing Period runs from ________ until _______.
The
current number of shares issued and outstanding as of the Company are:
The
number of shares currently available for issuance on the SB-2 for the Equity
Line are:
_________________________
Regards,
Xxx
Xxxxxx Xxxx, CEO
-34-
EXHIBIT
D
PUT
SETTLEMENT SHEET
Date:
Dear
Xx.
Xxxx,
Pursuant
to the Put given by SportsQuest, Inc., to Dutchess Private Equities Fund, Ltd.
on _________________ 200_, we are now submitting the amount of common shares
for
you to issue to Dutchess.
Please
have a certificate bearing no restrictive legend totaling __________ shares
issued to Dutchess Private Equities Fund, Ltd. immediately and send via DWAC
to
the following account:
XXXXXX
If
not
DWAC eligible, please send FedEx Priority Overnight to:
XXXXXX
Once
these shares are received by us, we will have the funds wired to the Company.
Regards,
Xxxxxxx
X. Xxxxxxxx
-35-
DATE
|
PRICE
|
Date
of Day 1
|
Closing
Bid of Day 1
|
Date
of Day 2
|
Closing
Bid of Day 2
|
Date
of Day 3
|
Closing
Bid of Day 3
|
Date
of Day 4
|
Closing
Bid of Day 4
|
Date
of Day 5
|
Closing
Bid of Day 5
|
LOWEST
1
(ONE) CLOSING BID IN PRICING PERIOD
------------
PUT
AMOUNT
------------
AMOUNT
WIRED TO COMPANY
------------
PURCHASE
PRICE (93)% (NINETY-THREE PERCENT))
------------
AMOUNT
OF
SHARES DUE
------------
The
undersigned has completed this Put as of this ___th day of _________, 200_.
Xxx
Xxxxxx Xxxx, CEO
-36-